Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
about
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Phase II study to evaluate the ...... oncomitant temozolomide (TMZ).
@en
Phase II study to evaluate the safety and efficacy of intravenous palonosetron
@nl
type
label
Phase II study to evaluate the ...... oncomitant temozolomide (TMZ).
@en
Phase II study to evaluate the safety and efficacy of intravenous palonosetron
@nl
prefLabel
Phase II study to evaluate the ...... oncomitant temozolomide (TMZ).
@en
Phase II study to evaluate the safety and efficacy of intravenous palonosetron
@nl
P2093
P2860
P50
P1476
Phase II study to evaluate the ...... oncomitant temozolomide (TMZ).
@en
P2093
Frances McSherry
James E Herndon
James J Vredenburgh
Karen Allen
Katherine B Peters
Mary Lou Affronti
Patrick N Healy
Sarah Woodring
P2860
P2888
P304
P356
10.1007/S00520-016-3276-1
P577
2016-06-06T00:00:00Z